MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Panellists at Patient Community Day 2026, held at the conclusion of MSToronto2026, are shown in discussion on stage.

Patient Community Day at MSToronto2026

MStranslate
November 6, 2026
Community, ECTRIMS, Events, Research
The word Toronto is shown displayed in large lettering on the edge of what could be a town square in downtown Toronto.

The ECTRIMS Podcast at MSToronto2026

MStranslate
November 5, 2026
Conferences, ECTRIMS, Research
1 Comment
3D medical illustration of HIV virus cells.

Antiviral Reverses Disability in Mouse Model of MS

MStranslate
September 28, 2026
Research, Treatments
cognition

Assessing & Monitoring Cognition in MS

MStranslate
August 11, 2026
Cognition, Research
News

Potential Changes to MS Treatment Access in Australia

MStranslate
July 2, 2026
Treatments
research update

Multiple Sclerosis Research Update – December 2020

MStranslate
December 15, 2020
Progressive MS, Research, Stem Cells, Treatments
With the end of 2020 approaching (I don’t think anyone is going to miss it), we thought we would try out a new style of research update.  Generally, our articles are an in-depth look at a specific study...
MS Virtual 2020

MS Virtual 2020: An In-depth Interview Series

MStranslate
October 29, 2020
Conferences, MS Virtual, Q&A, Research
1 Comment
As our daily coverage of MS Virtual 2020 demonstrated, there we many fascinating presentations delivered across the three days of the conference, covering a vast spectrum of multiple sclerosis research topics...
MS Virtual 2020

MS Virtual 2020: Review of Our Day 3 Coverage

MStranslate
September 23, 2020
Conferences, MS Virtual, Research
Due to the coronavirus pandemic, this year’s joint ACTRIMS-ECTRIMS Congress, which was meant to take place in Washington DC, became MS Virtual 2020, a conference conducted entirely online. We are pleased...
MS Virtual 2020

MS Virtual 2020: Review of Our Day 2 Coverage

MStranslate
September 18, 2020
Conferences, MS Virtual, Research
1 Comment
Due to the coronavirus pandemic, this year’s joint ACTRIMS-ECTRIMS Congress, which was meant to take place in Washington DC, became MS Virtual 2020, a conference conducted entirely online. We are pleased...
MS Virtual 2020

MS Virtual 2020: Review of Our Day 1 Coverage

MStranslate
September 14, 2020
Conferences, MS Virtual, Research
2 Comments
Due to the coronavirus pandemic, this year's joint ACTRIMS-ECTRIMS Congress, which was meant to take place in Washington DC, became MS Virtual 2020, a conference conducted entirely online. We are pleased to...
MS Virtual 2020

MS Virtual 2020: Looking Forward to the Week Ahead

MStranslate
September 8, 2020
Conferences, MS Virtual, Research
1 Comment
The world’s largest multiple sclerosis conference begins this week.  ECTRIMS (the European Committee for Treatment and Research In Multiple Sclerosis) brings together researchers and clinicians from around...
Anacardic Acid

Anacardic Acid: Potential Myelin Repair Therapy

MStranslate
August 25, 2020
Remyelination, Research
3 Comments
Remyelination is the next ‘big thing’ in the treatment and management of multiple sclerosis.  The ability to repair damaged myelin in people living with multiple sclerosis has the potential to not only...
calorie restriction

Calorie Restriction Promotes Myelin Repair

MStranslate
August 5, 2020
Diet, Lifestyle, Remyelination, Research
Research Summary: Calorie restriction promotes remyelination in a Cuprizone-Induced demyelination mouse model of multiple sclerosis Remyelination or myelin repair is the current ‘holy grail’ of multiple...
millennium

MS Research in the New Millennium: 2000 – 2020

MStranslate
July 23, 2020
Research, Treatments
It’s been 20 years since the world nervously welcomed the new millennium.  Let’s look back on those two decades and examine the major developments in Multiple Sclerosis research and treatment. Twenty...
bile acids

Bile Acids May Play Role in Multiple Sclerosis

MStranslate
June 23, 2020
Research, Treatments
2 Comments
Research Summary: Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation A joint investigation undertaken by researchers at Johns Hopkins University, the...
  1. 4
  2. 5
  3. 6
  4. 7
  5. 8
  6. 9
  7. 10

Recent Posts

  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia

Recent Comments

  • Patient Community Day at MSToronto2026 on The ECTRIMS Podcast at MSToronto2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • K on Multiple Sclerosis Research In 2026
  • Mohammad on Multiple Sclerosis Research In 2026

Calendar

November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Sep    

Archives

Categories

Posts

  • Patient Community Day at MSToronto2026
  • The ECTRIMS Podcast at MSToronto2026
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.